Lymphocyte-rich renal cell carcinoma: An unusual histomorphologic manifestation of a tumor that is not part of lynch syndrome

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 6, 2011, Pages 519-527

  Petersson, Fredrik ^a,e   Šíma, Radek ^a   Sperga, Maris ^f   Kazakov, Dmitry V ^a   Michal, Michal ^a   Hora, Milan ^a   Ferda, Jiří ^a   Šulc, Miroslav ^b   Mičulka, Petr ^c   Haferník, Jiří ^d   Rychnovský, Jiří ^d   Hes, Ondřej ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Bioptical and Cytological Laboratory Chomutov   (Czech Republic)

^c Regional Hospital Vsetin   (Czech Republic)

^d Regional Hospital   (Czech Republic)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

Author keywords

immunohistochemistry; kidney; lymphocyte rich; Lynch syndrome; renal cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; VON HIPPEL LINDAU PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER CHEMOTHERAPY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MULTIMODALITY CANCER THERAPY; MUTATIONAL ANALYSIS; NEPHRECTOMY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MUTATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 81755161539     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31821a931f     Document Type: Article

References (59)

1. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758-1762.
2. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-1456. (Pubitemid 29258894)
3. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268. (Pubitemid 38256271)
4. Ligtenberg MJ, Kuiper RP, Chan TL, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 30 exons of TACSTD1. Nat Genet. 2009;41:112-117.
5. Hitchins MP, Wong JJ, Suthers G, et al. Inheritance of a cancerassociated MLH1 germ-line epimutation. N Engl J Med. 2007;356: 697-705.
6. Morak M, Schackert HK, Rahner N, et al. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur J Hum Genet. 2008;16:804-811. (Pubitemid 351865678)
7. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260: 812-816. (Pubitemid 23167611)
8. Aaltonen LA, Peltomaki P, Mecklin JP, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 1994;54:1645-1648. (Pubitemid 24116162)
9. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257. (Pubitemid 28521189)
10. Muller W, Burgart LJ, Krause-Paulus R, et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)-results of an international collaborative study. Fam Cancer. 2001;1:87-92. (Pubitemid 35221521)
11. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 1996;56: 4836-4840. (Pubitemid 26374414)
12. Kim H, Jen J, Vogelstein B, et al. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994;145:148-156. (Pubitemid 24217493)
13. Jenkins MA, Hayashi S, O'shea AM, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007;133:48-56. (Pubitemid 47039240)
14. Greenson JK, Huang SC, Herron C, et al. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol. 2009;33:126-133.
15. Mecklin JP, Sipponen P, Jarvinen HJ. Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum. 1986;29:849-853. (Pubitemid 17208885)
16. Jass JR, Smyrk TC, Stewart SM, et al. Pathology of hereditary nonpolyposis colorectal cancer. Anticancer Res. 1994;14:1631-1634. (Pubitemid 24356996)
17. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998;42:673-679. (Pubitemid 28261055)
18. Michael-Robinson JM, Biemer-Huttmann A, Purdie DM, et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut. 2001;48:360-366. (Pubitemid 32269564)
19. Smyrk TC, Watson P, Kaul K, et al. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91:2417-2422. (Pubitemid 32552830)
20. Young J, Simms LA, Biden KG, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159:2107-2116. (Pubitemid 33104265)
21. Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol. 2003;27:563-570. (Pubitemid 36514468)
22. Yearsley M, Hampel H, Lehman A, et al. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite- stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol. 2006;37:831-838. (Pubitemid 43902942)
23. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-544. (Pubitemid 27293491)
24. Lynch HT, Smyrk T, Lynch JF. Molecular genetics and clinicalpathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology. 1998;55:103-108.
25. Cantor D. The frustrations of families: Henry Lynch, heredity, and cancer control, 1962-1975. Med Hist. 2006;50:279-302. (Pubitemid 44882944)
26. Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med. 1966;117:206-212.
27. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215-1225. (Pubitemid 24006117)
28. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993;260: 810-812. (Pubitemid 23167610)
29. Peltomaki P, Lothe RA, Aaltonen LA, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 1993;53:5853-5855. (Pubitemid 24006147)
30. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75:1027-1038. (Pubitemid 24014559)
31. Lindblom A, Tannergard P, Werelius B, et al. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet. 1993;5:279-282. (Pubitemid 23330393)
32. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994;368:258-261.
33. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994;263: 1625-1629. (Pubitemid 24128369)
34. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80. (Pubitemid 24277467)
35. Akiyama Y, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 1997;57:3920-3923. (Pubitemid 27427676)
36. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997;17:271-272.
37. Peltomä ki P, Offerhaus G. WHO Classification of Tumours of the Digestive System. In: Bosman FT, ed. WHO Classification of Tumours. Lyon: IARC; 2010:152.
38. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71:677-685. (Pubitemid 23051366)
39. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979-1985. (Pubitemid 40570891)
40. De Jong AE, Hendriks YM, Kleibeuker JH, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology. 2006;130:665-671. (Pubitemid 43374516)
41. Orta L, Klimstra DS, Qin J, et al. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics. Am J Surg Pathol. 2009;33:934-944.
42. Honchel R, Halling KC, Schaid DJ, et al. Microsatellite instability in Muir-Torre syndrome. Cancer Res. 1994;54:1159-1163. (Pubitemid 24108050)
43. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med. 1995;332:839-847.
44. Grignon DJ, Eble JN, Bonsib SM, et al. Tumours of the urinary system and male genital organs. In: Eble JN, Sauter G, Epstein J, et al, eds. World Health Organization Classification of Tumours Pathology and Genetics. Lyon: IARC; 2004:23-29.
45. Lynch HT, Taylor RJ, Lynch JF, et al. Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications. Am J Gastroenterol. 2003;98:664-670. (Pubitemid 36348542)
46. Lynch MC, Anderson BE. Ileocecal adenocarcinoma and ureteral transitional cell carcinoma with multiple sebaceous tumors and keratoacanthomas in a case of Muir-Torre syndrome. Dermatol Res Pract. 2010;2010.pii:173160.
47. Van Der Post RS, Kiemeney LA, Ligtenberg MJ, et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet. 47:464-470.
48. Leach FS, Polyak K, Burrell M, et al. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res. 1996;56:235-240. (Pubitemid 26026346)
49. Wilson TM, Ewel A, Duguid JR, et al. Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res. 1995;55:5146-5150.
50. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch. 2004;445:431-441. (Pubitemid 39592745)
51. Shia J, Klimstra DS, Nafa K, et al. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol. 2005;29:96-104. (Pubitemid 40023956)
52. Christensen M, Katballe N, Wikman F, et al. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer. 2002;95: 2422-2430. (Pubitemid 35351151)
53. Mangold E, Pagenstecher C, Friedl W, et al. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J Pathol. 2005;207:385-395. (Pubitemid 43025686)
54. Wahlberg SS, Schmeits J, Thomas G, et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res. 2002;62:3485-3492. (Pubitemid 34651396)
55. De Jong AE, Van Puijenbroek M, Hendriks Y, et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:972-980. (Pubitemid 38198898)
56. Acharya S, Wilson T, Gradia S, et al. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci U S A. 1996;93:13629-13634. (Pubitemid 26424170)
57. Boland CR, Koi M, Chang DK, et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer. 2008;7:41-52.
58. Harfe BD, Minesinger BK, Jinks-Robertson S. Discrete in vivo roles for the MutL homologs Mlh2p and Mlh3p in the removal of frameshift intermediates in budding yeast. Curr Biol. 2000;10: 145-148. (Pubitemid 30115745)
59. Kanomata N, Eble JN, Halling KC. Microsatellite instability is uncommon in young patients with renal cell carcinoma. Cancer Genet Cytogenet. 1998;101:123-127. (Pubitemid 28141173)